Thompson Davis & Co’s BIND THERAPEUTICS INC BIND Stock Holding History

Thompson Davis & Co’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,500	Closed	-$20K	–	1278
2015 Q3	$20K	Sell	4,500 -1,000	-18%	-$4.91K	0.03%	475
2015 Q2	$31K	Sell	5,500 -3,000	-35%	-$18.6K	0.04%	421
2015 Q1	$47K	Buy	8,500 +7,500	+750%	+$46.1K	0.06%	306
2014 Q4	$5K	Sell	1,000 -23,425	-96%	-$176K	0.01%	966
2014 Q3	$210K	Sell	24,425 -6,325	-21%	-$62.4K	0.27%	82
2014 Q2	$423K	Buy	30,750 +25,750	+515%	+$252K	0.61%	34
2014 Q1	$60K	Buy	5,000 +3,500	+233%	+$45.7K	0.1%	229
2013 Q4	$23K	Buy	+1,500	New	+$19.1K	0.03%	334

Other funds holding BIND

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Thompson Davis & Co's BIND Position: Q4 2015 in Review

Thompson Davis & Co sold out of BIND THERAPEUTICS INC (BIND) in Q4 2015, closing a stake of 4,500 shares — an estimated $20K sold.

Thompson Davis & Co first reported a position in BIND in Q4 2013 and held it in 8 quarters. The position peaked at $423K in Q2 2014. 38 funds tracked by Wall St. Rank hold BIND as of Q4 2015.

Thompson Davis & Co reported no remaining BIND THERAPEUTICS INC position as of Q4 2015 after selling out during the quarter.
Thompson Davis & Co sold 4,500 BIND THERAPEUTICS INC shares in Q4 2015, an estimated $20K.
Thompson Davis & Co first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 8 quarters.
Thompson Davis & Co's BIND THERAPEUTICS INC position peaked at $423K in Q2 2014.
38 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q4 2015.

Based on Thompson Davis & Co's 13F filing for Q4 2015, filed 1 Feb 2016.